Related Experiment Video
Updated: Oct 2, 2026
Peptide Scanning-assisted Identification of a Monoclonal Antibody-recognized Linear B-cell Epitope
Published on: March 24, 2017
Monoclonal antibodies against foot-and-mouth disease virus 146S and 12S particles
Abstract:
This paper is the first description of monoclonal antibodies specific for foot-and-mouth disease virus (FMDV). Using these antibodies, it was possible to distinguish similar and unique antigenic sites on complete (146S) or subunit (12S) virus particles. Some of these monoclonal antibodies could also distinguish between 12S subunits made by acid degradation of 146S virus (12SA) and those viral components found in infected cell lysates which sediment in sucrose density gradients as "12S subunits" (12SN).
Insights
This study introduces novel monoclonal antibodies for foot-and-mouth disease virus (FMDV). These antibodies effectively differentiate unique antigenic sites on FMDV particles and subunits, aiding in precise viral characterization.
Area of Science:
- Virology
- Immunology
- Molecular Biology
Background:
- Foot-and-mouth disease virus (FMDV) poses a significant threat to livestock globally.
- Accurate characterization of FMDV antigenic sites is crucial for vaccine development and diagnostics.
- Previous methods lacked the specificity to differentiate subtle antigenic variations within FMDV particles.
Purpose of the Study:
- To develop and characterize monoclonal antibodies specific to foot-and-mouth disease virus (FMDV).
- To utilize these antibodies to distinguish between similar and unique antigenic sites on FMDV.
- To differentiate between FMDV subunits derived from acid degradation and those from infected cell lysates.
Main Methods:
- Production of monoclonal antibodies targeting FMDV.
- Immunological assays to assess antibody specificity against complete (146S) and subunit (12S) FMDV particles.
- Distinction between acid-degraded (12SA) and cell lysate-derived (12SN) 12S subunits using monoclonal antibodies.
Main Results:
- The study reports the first description of monoclonal antibodies specific for FMDV.
- These antibodies successfully identified distinct antigenic sites on both 146S and 12S FMDV particles.
- Specific monoclonal antibodies differentiated between 12SA and 12SN FMDV subunits.
Conclusions:
- Novel monoclonal antibodies provide a powerful tool for precise antigenic characterization of FMDV.
- These antibodies enable differentiation of FMDV structural components, including subunits from different sources.
- This advancement has implications for improved FMDV diagnostics, vaccine design, and epidemiological studies.
